UT StrokeNet
UT 中风网
基本信息
- 批准号:10471994
- 负责人:
- 金额:$ 30.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:Active LearningAcuteAddressAdultAgreementAreaArizonaBiological MarkersBlood VesselsCaringChildhoodChildhood strokeClinicalClinical ResearchClinical SciencesClinical TrialsCollaborationsColoradoDevelopmentDisciplineEducationEnrollmentEtiologyExtramural ActivitiesFacultyFosteringFoundationsFundingGeographyGoalsGrantHealthHealth systemHospitalsHumanImageInstitutesInstitutional Review BoardsInterdisciplinary StudyJournalsLaboratoriesLeadLeadershipLinkLocationMedicalMentorsMethodologyMinorityMinority RecruitmentNCI Scholars ProgramNational Institute of Neurological Disorders and StrokeNetwork InfrastructureNeurologyOutcome MeasureParticipantPatientsPediatric HospitalsPersonsPopulationPopulation HeterogeneityPositioning AttributePostdoctoral FellowPublic HealthRecoveryRehabilitation therapyResearchResearch PersonnelResearch Project GrantsResourcesRuralSiteStrokeStroke VolumeStroke preventionTalentsThrombosisTimeTrainingTraining ProgramsTranslational ResearchUnited States National Institutes of HealthUniversitiesUtahVertebral columnWomancareercareer developmentcareer networkingclinical centerclinical investigationcostcultural competencedata qualitydesigndisabilityeffectiveness trialelectronic data capture systemexperiencefrontierimaging biomarkerimprovedinnovationinterdisciplinary collaborationinvestigator trainingmortalitymultidisciplinaryneurovascular couplingoperationoutreachprogramsracial diversityrehabilitation sciencesexskill acquisitionstroke clinical trialsstroke patientstroke rehabilitationstroke trialssuccesstelestroketraining opportunitytranslational neurosciencetranslational scientist
项目摘要
The last decade has seen significant advances in stroke prevention, treatment, rehabilitation,
and recovery. Yet, more externally valid effectiveness trials with diverse populations are critical.
Current stroke trials are challenged by inefficiencies, such as multiple institutional review
boards, trial agreements, and trial networks, which can lead to slow or incomplete enrollment,
variable quality, and high costs. The NIH Stroke Trials Network (StrokeNet) was founded with
the purpose of addressing these issues. The use of a central IRB, Master Trial Agreement and
use of a single electronic data capture system (webDCU) were implemented with to reduce
start-up times and improve data quality. Inclusion of centers across the US aims to increase
participant numbers and diversity. University of Utah Health (UUH) is a highly successful NIH
StrokeNet Regional Coordinating Center (RCC). Utah (UT) StrokeNet is centered in the
Mountain West, a 5-state region covering 10% of the U.S. landmass with 12.8 million
inhabitants of increasing diversity. UT StrokeNet includes 9 Clinical Performing Sites (CPS), 8
adult and 1 pediatric, in Utah, Colorado, and Arizona. In the next funding period, UT StrokeNet
will continue to efficiently implement and successfully conduct multiple adult and pediatric
StrokeNet trials using the combined strength of all 9 sites. UT StrokeNet aims to provide access
to high quality, innovative trials to all Mountain West stroke patients, regardless of patient sex or
location. UT StrokeNet will focus on further increasing minority recruitment by providing cultural
competency training to its study teams as well as maximizing access to clinical trials for patients
living in rural and frontier areas through the use of the Telestroke Network. The local leadership
team will continue to serve on national network committees to contribute to StrokeNet
operations. UT StrokeNet will also facilitate multi-disciplinary collaborations of local clinical and
translational stroke experts (with a strong focus on stroke rehabilitation) in order to propose
innovative trials to NINDS and the Network. UT StrokeNet will foster the education and career
development of post-doctoral clinical and translational scientists through a focused,
individualized training program that includes experiential learning, optional coursework, and
career and research mentoring. By achieving these goals, UT StrokeNet will contribute to the
continued development of the national stroke trials network, advancement of stroke research,
and, ultimately, an improvement of stroke care for all persons in the Mountain West.
在过去的十年里,中风的预防、治疗、康复、
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Juhl Majersik其他文献
Ethics and Bias in Clinical Trial Enrollment in Stroke
- DOI:
10.1007/s11886-019-1139-3 - 发表时间:
2019-04-22 - 期刊:
- 影响因子:3.300
- 作者:
Jennifer Juhl Majersik - 通讯作者:
Jennifer Juhl Majersik
Jennifer Juhl Majersik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Juhl Majersik', 18)}}的其他基金
IDENTIFYING PRE-DIABETES IN THE SETTING OF ACUTE CEREBRAL ISCHEMIA
在急性脑缺血的情况下识别糖尿病前期
- 批准号:
7603840 - 财政年份:2007
- 资助金额:
$ 30.5万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Operating Grants














{{item.name}}会员




